Untitled Document
Hathaway Corporation - Your next step

Call Us: 817-812-2104
"The future is now"
Building tomorrow's technology through today's innovations.
 
 


 Home:  
 
About Hathaway Companies Investors Contact Us

Company news:

Corporate Home:


Stock quote
: HWYI

Opticon Systems Home:
Diabetic Detection Inc:

Hathaway (HWYI) Enters into LOI with Korean
Medical device Manufacturer, U & I Bio-Tech, Inc.
More >>

Hathaway (HWYI) Subsidiary OptiCon Systems, Inc. Receives Trading
Symbol from FINRA
More >>

Hathaway (HWYI) to Begin Spin-Off of Subsidiary Diabetes Detection Inc.
More >>

Hathaway Corporation Provides Information on Diabetes Detection, Inc. Inventor
Tuesday April 4, 2006

Wholly Owned Subsidiary of Hathaway to Develop Vibrameter, World's Only Early Detection Device for Diabetes Using Mobile Devices

Hathaway Corporation is pleased to announce information on the inventor of Vibrameter, Dr. Ajay Gupta, from Diabetes Detection, Inc. Vibrameter is the only device that utilizes current hand-held communication devices for use in the early detection of diabetes.

Dr. Gupta's qualifications are as follows;

1995-2001 -- Senior Staff Physician, Henry Ford Hospital, 2001-Present -- Associate Professor of Medicine, Charles R. Drew University of Medicine and Science; 2002-Present -- Associate Clinical Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles; 2002-2005 -- Associate Chief, Division of Nephrology & Hypertension King/Drew Medical Center, Los Angeles, California; June 2005 -- Acting Chief, Division of Nephrology & Hypertension, King/Drew Medical Center, Los Angeles, California; Nov 2005-Present -- Interim Medical Director, Renal Advantage Inc. Dialysis Center, Los Angeles

PATENTS ISSUED/FILED/LICENSED

Method and pharmaceutical composition for replacing iron losses in hemodialysis patients. US 6,689,275 B1, Feb. 10, 2004 (Issued). LICENSED TO Rockwell Medical Technologies, Inc., Wixom, Michigan

Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients. US 6,779,468 B1, Aug. 24, 2004 (Issued). LICENSED TO Rockwell Medical Technologies, Inc., Wixom, Michigan

Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients. EP 0 951 470 B1, Nov. 30, 2005 (Issued). LICENSED TO Rockwell Medical Technologies, Inc., Wixom, Michigan

Dialysis solutions containing water-soluble vitamins and nutrients. US 6,537,976 B1, Mar. 25, 2003 (Issued). LICENSED TO Rockwell Medical Technologies, Inc., Wixom, Michigan

Method and combination electronic communication and medical diagnostic apparatus for detecting/monitoring neuropathy. U.S. Priority App. S.N. : 10/725,393, Dec. 3, 2003 (Filed). LICENSED TO Diabetes Detection, Inc.

About Hathaway Corporation

Hathaway Corporation develops and acquires undervalued companies that bring a shift in how communications are delivered and serviced globally. Hathaway continues to seek out and capitalize on emerging technologies such as OptiCon Systems that will change the way the world communicates. Originally, OptiCon Systems was developed by Corning and sold to their customers. Corning spent millions of dollars and over seven years developing the Fiber Optic Management System currently marketed and sold by OptiCon Systems Inc. OptiCon serves over 70% of the Global 500 companies such as Adelphia, Charter, Comcast, Comcast/AT&T, Cox, Time Warner, and Bright House. Through companies like OptiCon, Hathaway brings the communication solutions of the future to today's business marketplace.

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Back >>

Untitled Document
Home | About |Companies |Investors | Contact Us
© 2008 - Hathaway Global, inc. , all rights reserved